Physician profile
Melanie Baum
NPI 1366049264
$3,362.96
in general payments reported to CMS, 2019-2025
14 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $238 · 2023: $743 · 2024: $1,696 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,204 · Travel and Lodging: $630 · Education: $15.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,203.55 |
| Travel and Lodging | $630.39 |
| Education | $15.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,583.44 | 2021-2025 | Watchman Flx |
| Biosense Webster, INC. | $393.72 | 2023-2024 | Carto 3 |
| Janssen Pharmaceuticals, INC | $271.86 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $251.39 | 2021-2023 | Abilify |
| Pfizer INC. | $216.66 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $186.17 | 2023-2024 | |
| Novo Nordisk INC | $177.05 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $91.51 | 2022 | |
| Medtronic, INC. | $86.69 | 2022-2023 | Reveal Linq |
| Philips North America LLC | $41.78 | 2025 | Ecc Solutions, Mcot |
| Kestra Medical Technology Services, INC. | $16.62 | 2023 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $16.13 | 2023 | Arcalyst |
| Abbott Laboratories | $15.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.83 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.